Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation

Oncogene volume 24, pages 1698–1710 (2005)Cite this article

Abstract

The btg1 (B-cell translocation gene 1) gene coding sequence was isolated from a translocation break point in a case of B-cell chronic lymphocytic leukaemia. We have already shown that BTG1, considered as an antiproliferative protein, strongly stimulates myoblast differentiation. However, the mechanisms involved in this influence remained unknown. In cultured myoblasts, we found that BTG1 stimulates the transcriptional activity of nuclear receptors (T3 and all-trans retinoic acid receptors but not RXRα and PPARγ), c-Jun and myogenic factors (CMD1, Myf5, myogenin). Immunoprecipitation experiments performed in cells or using in vitro-synthesized proteins and GST pull-down assays established that BTG1 directly interacts with T3 and all-trans retinoic acid receptors and with avian MyoD (CMD1). These interactions are mediated by the transactivation domain of each transcription factor and the A box and C-terminal part of BTG1. NCoR presence induces the ligand dependency of the interaction with nuclear receptors. Lastly, deletion of BTG1 interacting domains abrogates its ability to stimulate nuclear receptors and CMD1 activity, and its myogenic influence. In conclusion, BTG1 is a novel important coactivator involved in the regulation of myoblast differentiation. It not only stimulates the activity of myogenic factors, but also of nuclear receptors already known as positive myogenic regulators.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10

Similar content being viewed by others

References

  • Albagli-Curiel O, Carnac G, Vandromme M, Vincent S, Crepieux P and Bonnieu A . (1993). Differentiation, 52, 201–210.

  • Andersson ML, Nordstrom K, Demczuk S, Harbers M and Vennstrom B . (1992). Nucleic Acids Res., 20, 4803–4810.

  • Angel P, Baumann I, Stein B, Delius H, Rahmsdorf HJ and Herrlich P . (1987). Mol. Cell. Biol., 7, 2256–2266.

  • Antin PB and Ordahl CP . (1991). Dev. Biol., 143, 111–121.

  • Bakker WJ, Blazquez-Domingo M, Kolbus A, Besooyen J, Steinlein P, Beug H, Coffer PJ, Lowenberg B, Von Lindern M and Van Dijk TB . (2004). J. Cell Biol., 164, 175–184.

  • Berthet C, Guehenneux F, Revol V, Samarut C, Lukaszewicz A, Dehay C, Dumontet C, Magaud JP and Rouault JP . (2002). Genes Cells, 7, 29–39.

  • Bradbury A, Possenti R, Shooter EM and Tirone F . (1991). Proc. Natl. Acad. Sci. USA, 88, 3353–3357.

  • Casas F, Domenjoud L, Rochard P, Hatier R, Rodier A, Daury L, Bianchi A, Kremarik-Bouillaud P, Becuwe P, Keller J, Schohn H, Wrutniak-Cabello C, Cabello G and Dauca M . (2000). FEBS Lett., 478, 4–8.

  • Casas F, Rochard P, Rodier A, Cassar-Malek I, Marchal-Victorion S, Wiesner RJ, Cabello G and Wrutniak C . (1999). Mol. Cell. Biol., 19, 7913–7924.

  • Cassar-Malek I, Marchal S, Altabef M, Wrutniak C, Samarut J and Cabello G . (1994). Oncogene, 9, 2197–2206.

  • Cassar-Malek I, Marchal S, Rochard P, Casas F, Wrutniak C, Samarut J and Cabello G . (1996). J. Biol. Chem., 271, 11392–11399.

  • Chen D, Ma H, Hong H, Koh SS, Huang SM, Schurter BT, Aswad DW and Stallcup MR . (1999). Science, 284, 2174–2177.

  • Daury L, Busson M, Tourkine N, Casas F, Cassar-Malek I, Wrutniak-Cabello C, Castellazzi M and Cabello G . (2001). Oncogene, 20, 7998–8008.

  • Forman BM, Yang CR, Au M, Casanova J, Ghysdael J and Samuels HH . (1989). Mol. Endocrinol., 3, 1610–1626.

  • Heery DM, Kalkhoven E, Hoare S and Parker MG . (1997). Nature, 387, 733–736.

  • Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK and Rosenfeld G . (1995). Nature, 377, 397–404.

  • Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK and Rosenfeld MG . (1996). Cell, 85, 403–414.

  • Ko L, Cardona GR and Chin WW . (2000). Proc. Natl. Acad. Sci. USA, 97, 6212–6217.

  • Koh SS, Chen D, Lee YH and Stallcup MR . (2001). J. Biol. Chem., 276, 1089–1098.

  • Lin WJ, Gary JD, Yang MC, Clarke S and Herschman HR . (1996). J. Biol. Chem., 271, 15034–15044.

  • Malik S, Huang CF and Schmidt J . (1995). Eur. J. Biochem., 230, 88–96.

  • Marchal S, Cassar-Malek I, Magaud JP, Rouault JP, Wrutniak C and Cabello G . (1995). Exp. Cell Res., 220, 1–10.

  • Matsuda S, Kawamura-Tsuzuku J, Ohsugi M, Yoshida M, Emi M, Nakamura Y, Onda M, Yoshida Y, Nishiyama A and Yamamoto T . (1996). Oncogene, 12, 705–713.

  • Monden T, Wondisford FE and Hollenberg AN . (1997). J. Biol. Chem., 272, 29834–29841.

  • Nielsen DA, Chou J, MacKrell AJ, Casadaban MJ and Steiner DF . (1983). Proc. Natl. Acad. Sci. USA, 80, 5198–5202.

  • Prevot D, Morel AP, Voeltzel T, Rostan MC, Rimokh R, Magaud JP and Corbo L . (2001). J. Biol. Chem., 276, 9640–9648.

  • Prevot D, Voeltzel T, Birot AM, Morel AP, Rostan MC, Magaud JP and Corbo L . (2000). J. Biol. Chem., 275, 147–153.

  • Puigserver P, Wu Z, Park CW, Graves R, Wright M and Spiegelman BM . (1998). Cell, 92, 829–839.

  • Rodier A, Marchal-Victorion S, Rochard P, Casas F, Cassar-Malek I, Rouault JP, Magaud JP, Mason DY, Wrutniak C and Cabello G . (1999). Exp. Cell Res., 249, 337–348.

  • Rodier A, Rochard P, Berthet C, Rouault JP, Casas F, Daury L, Busson M, Magaud JP, Wrutniak-Cabello C and Cabello G . (2001). Oncogene, 20, 2691–2703.

  • Rouault JP, Falette N, Guehenneux F, Guillot C, Rimokh R, Wang Q, Berthet C, Moyret-Lalle C, Savatier P, Pain B, Shaw P, Berger R, Samarut J, Magaud JP, Ozturk M, Samarut C and Puisieux A . (1996). Nat. Genet., 14, 482–486.

  • Rouault JP, Prevot D, Berthet C, Birot AM, Billaud M, Magaud JP and Corbo L . (1998). J. Biol. Chem., 273, 22563–22569.

  • Rouault JP, Rimokh R, Tessa C, Paranhos G, Ffrench M, Duret L, Garoccio M, Germain D, Samarut J and Magaud JP . (1992). EMBO J., 11, 1663–1670.

  • Rowe A, Eager NS and Brickell PM . (1991). Development, 111, 771–778.

  • Samuels HH, Stanley F and Casanova J . (1979). Endocrinology, 105, 80–85.

  • Sartorelli V, Huang J, Hamamori Y and Kedes L . (1997). Mol. Cell. Biol., 17, 1010–1026.

  • Snedecor GW . (1961). Statistical Methods. Iowa State University Press: Ames, IA, p. 534.

    Google Scholar 

  • Treuter E, Albrektsen T, Johansson L, Leers J and Gustafsson JA . (1998). Mol. Endocrinol., 12, 864–881.

  • Vial E, Perez S and Castellazzi M . (2000). Oncogene, 19, 5020–5029.

  • Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD and Fletterick RJ . (1995). Nature, 378, 690–697.

  • Weintraub H, Dwarki VJ, Verma I, Davis R, Hollenberg S, Snider L, Lassar A and Tapscott SJ . (1991). Genes Dev., 5, 1377–1386.

  • Wigler M, Pellicer A, Silverstein S and Axel R . (1978). Cell, 14, 725–731.

  • Yoshida M, Horinouchi S and Beppu T . (1995). BioEssays, 17, 423–430.

  • Yoshida Y, Matsuda S, Ikematsu N, Kawamura-Tsuzuku J, Inazawa J, Umemori H and Yamamoto T . (1998). Oncogene, 16, 2687–2693.

Download references

Acknowledgements

We are grateful to Dr Samarut, Dr Flamant (ENS Lyon, France), Pr P Chambon (LGME Strasbourg, France), Dr PK Vogt (The Scripps Institute, La Jolla, CA), Dr D Montaras (Institut Pasteur, Paris, France), Dr C Deschene (INSERM Nice, France), Dr PB Antin and Dr CP Ordhal (San Francisco, California), Dr LJ De Groot (Chicago, Illinois), Pr BM Paterson (University of Washington, Seattle) and Dr F Pons (INSERM Montpellier, France) for the gift of plasmids, the QM7 myoblast line and the antibodies α17, anti-CMD1, anti-connectin and anti-myosin. This work was supported by INRA (Institut National de Recherche Agronomique), grants from AFM (Association Française pour la recherche contre les Myopathies) and ARC (Association pour la Recherche contre le Cancer). Muriel Busson is a recipient of fellowships from MNRT (Ministère de la Recherche) and ARC.

Author information

Authors and Affiliations

  1. UMR 866 Différenciation Cellulaire et Croissance, INRA, 2 place Viala, 34060, Montpellier Cedex, 1, France

    Muriel Busson, Angel Carazo, Pascal Seyer, Stéphanie Grandemange, François Casas, Laurence Pessemesse, Chantal Wrutniak-Cabello & Gérard Cabello

  2. INSERM U418, Hopital Debrousse, 29 rue soeur Bouvier, 69322, Lyon Cedex, 05, France

    Jean-Pierre Rouault

Authors
  1. Muriel Busson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Angel Carazo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pascal Seyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stéphanie Grandemange
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. François Casas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Laurence Pessemesse
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jean-Pierre Rouault
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chantal Wrutniak-Cabello
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Gérard Cabello
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gérard Cabello.

Additional information

Supplementary Information accompanies the paper on Oncogene website (http://www.nature.com/onc)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Busson, M., Carazo, A., Seyer, P. et al. Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation. Oncogene 24, 1698–1710 (2005). https://doi.org/10.1038/sj.onc.1208373

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208373

Keywords

This article is cited by

Search

Advanced search

Quick links